CRDL vs. NVDA
Compare and contrast key facts about Cardiol Therapeutics Inc Class A (CRDL) and NVIDIA Corporation (NVDA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CRDL or NVDA.
Correlation
The correlation between CRDL and NVDA is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CRDL vs. NVDA - Performance Comparison
Key characteristics
CRDL:
0.22
NVDA:
1.63
CRDL:
1.09
NVDA:
2.17
CRDL:
1.12
NVDA:
1.28
CRDL:
0.24
NVDA:
3.42
CRDL:
0.57
NVDA:
9.49
CRDL:
34.55%
NVDA:
9.75%
CRDL:
90.44%
NVDA:
56.82%
CRDL:
-92.71%
NVDA:
-89.73%
CRDL:
-80.29%
NVDA:
-7.08%
Fundamentals
CRDL:
$99.85M
NVDA:
$3.40T
CRDL:
-$0.37
NVDA:
$2.53
CRDL:
$0.00
NVDA:
$91.17B
CRDL:
-$123.53K
NVDA:
$69.14B
CRDL:
-$29.96M
NVDA:
$60.32B
Returns By Period
In the year-to-date period, CRDL achieves a -4.69% return, which is significantly lower than NVDA's 3.40% return.
CRDL
-4.69%
-0.81%
-39.15%
-17.57%
-17.05%
N/A
NVDA
3.40%
1.92%
11.47%
91.14%
80.92%
74.47%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CRDL vs. NVDA — Risk-Adjusted Performance Rank
CRDL
NVDA
CRDL vs. NVDA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Cardiol Therapeutics Inc Class A (CRDL) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CRDL vs. NVDA - Dividend Comparison
CRDL has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRDL Cardiol Therapeutics Inc Class A | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.02% | 0.02% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% | 1.70% |
Drawdowns
CRDL vs. NVDA - Drawdown Comparison
The maximum CRDL drawdown since its inception was -92.71%, roughly equal to the maximum NVDA drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for CRDL and NVDA. For additional features, visit the drawdowns tool.
Volatility
CRDL vs. NVDA - Volatility Comparison
The current volatility for Cardiol Therapeutics Inc Class A (CRDL) is 22.89%, while NVIDIA Corporation (NVDA) has a volatility of 24.49%. This indicates that CRDL experiences smaller price fluctuations and is considered to be less risky than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CRDL vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between Cardiol Therapeutics Inc Class A and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities